Q3 2025 Embla Medical hf Earnings Call Transcript

Oct 21, 2025 / 07:00 AM GMT

Release Date Price: $4.8

Transcript

Key Points

Positve

Embla Medical hf (OSSFF) reported a 7% organic growth in sales for Q3 2025, with a total reported growth of 11% including FX and M&A impacts.
The company's prosthetics and neuro orthotics segments experienced strong momentum, with organic growth of 13% in the third quarter.
Embla Medical hf (OSSFF) successfully launched the Odyssey IQ, a new hydraulic microprocessor foot solution, which received a positive market reception in the Americas.
The company achieved a strong EBITDA margin of 22% for the quarter, maintaining its performance from the previous year.
Embla Medical hf (OSSFF) reiterated its full-year guidance, expecting 5-6% organic growth and a 20-21% EBITDA margin, indicating confidence in its strategic direction.

Negative

The patient care segment showed modest growth of only 1% for the quarter, with performance below market expectations.
Embla Medical hf (OSSFF) faced challenges in the US market due to tariffs, impacting profitability and requiring mitigation strategies.
The company experienced internal disruptions in its patient care business due to rebranding and system integration initiatives, affecting growth.
Bracing and support sales remained flat, with the US market particularly impacted by tariffs and channel structure changes.
The potential impact of a US Department of Commerce investigation into medical consumables and equipment remains uncertain, posing a risk to future operations.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EMBLA.CO - Embla Medical hf
Q3 2025 Embla Medical hf Earnings Call
Oct 21, 2025 / 07:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
At this time I would like to welcome everyone to this Q3 2025 conference call. Today's call is being recorded. If you have any objections, please disconnect at this time. All participants will be on listen no mode throughout the presentation, and afterwards there'll be a question-and-answer session.

I would now like to introduce President and CEO Sven Silverson and CFO Anna Svensader. I will now send the call over to your speakers. You may now begin your presentation.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good morning and welcome to the ATLA

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.